Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by lonc17on Feb 28, 2024 5:02pm
107 Views
Post# 35904967

RE:RE:RE:RE:RE:RE:New Press Release - Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

RE:RE:RE:RE:RE:RE:New Press Release - Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer ConferenceThere are dozens of these small (non-academic) conferences held every year accross North America. 

They serve two purposes:

1. They allow for some professional course credits for health care professionals to satisfy their professional obligations. 

2. They are marketing tools for big pharma to promote existing approved therapuetics. 

Suggesting that MC and ONC are somehow accessing the eyes and ears of BP by attending this event, is a bit like suggesting that a small tech CEO with a cool idea could establish partnership dialogue with APPLE by going in to an Apple Store. 

MC problably has a family/friend wedding in New Orlean's this week and is more than happy to access his $1500 per diem and have his flights paid.... all he needs to do is present for 30 minutes to a group of five or six people. 




<< Previous
Bullboard Posts
Next >>